Search Results 41-50 of 16722 for GLP-1 agonists
GLP-1RA Use and Thyroid Cancer Risk. JAMA Otolaryngol Head Neck Surg. 2025 ... Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium ...
Angioedema (swelling of the face, lips, tongue, throat, arms, or legs) caused by GLP-1 receptor agonists, history of—Use with caution. ... It is not safe for one ...
GLP-1 receptor agonists are medicines taken by shot, called injection. They slow digestion and help lower blood sugar levels. Their use is often linked with ...
Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia. Anesth Analg. 2026 Apr 1; 142 ...
Glucagon-Like Peptide-1 Agonist Use in Adults With Congenital Heart Disease: Effect, Safety, and Outcomes. JACC Adv. 2025 Apr; 4(4):101674. Epub 2025 Mar 24.
GLP-1 receptor agonists as pharmacological treatment for obesity after spinal cord injury: clinical considerations. Arch Phys Med Rehabil. 2026 Mar 11 [Epub ...
... GLUCAGON-LIKE PEPTIDE-1 AGONISTS. Clin Gastroenterol Hepatol. 2026 Mar 11 [Epub ahead of print] View PubMed; Lunsford TN, Frazier R, Harris LA. How I ...
... agonist pioglitazone, with or without weight loss ... one of 6 specific gene defects in the Melanocortin-4 Receptor pathway. ... Data has shown that the ...
... GLP-1 receptor agonist medications. "Once you have the procedure, you've had it, and no one is going to take that away from you or change your insurance ...
You step on the scale and the numbers are moving in the right direction after taking one of the popular injectable weight-loss drugs. But now you want to stop ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.